Clinical Trials on Human Endotoxaemia in South Africa
Total 556 results
-
Novartis VaccinesDepartment of Health and Human ServicesCompletedPandemic H5N1 InfluenzaUnited States, Australia, Thailand
-
Novartis VaccinesCompletedNovel 2009 Influenza H1N1Costa Rica
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Sekisui Diagnostics, LLCCompleted
-
Kirby InstituteCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Novartis VaccinesDepartment of Health and Human ServicesCompletedPandemic H5N1 InfluenzaUnited States, Australia, New Zealand, Thailand
-
Bristol-Myers SquibbCompleted
-
Kirby InstituteRecruitingHepatitis BAustralia
-
Prisma Health-UpstateGilead SciencesCompletedHepatitis C | Substance Use DisordersUnited States
-
NovavaxTerminatedInfluenza, HumanUnited States
-
GlaxoSmithKlineCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedCommunicable Diseases | Hepatitis B | HIV | Infectious Diseases | HBVUnited Kingdom
-
Kirby InstituteCompleted
-
GlaxoSmithKlineCompletedHepatitis BAustralia, Belgium
-
Ology BioservicesCompleted
-
VaxInnate CorporationUnknown
-
National Taipei University of Nursing and Health...CompletedHuman Immunodeficiency VirusIndonesia
-
Vaxxas Pty LtdBiomedical Advanced Research and Development AuthorityNot yet recruiting
-
Kirby InstituteAbbVieCompletedHepatitis C, AcuteUnited Kingdom, Australia, New Zealand
-
University of MelbourneLondon School of Hygiene and Tropical Medicine; The Alfred; University of Adelaide and other collaboratorsRecruitingInfluenza, Human | SARS-CoV-2 InfectionAustralia
-
Kirby InstituteNational Institutes of Health (NIH); The University of New South WalesCompleted
-
BioCryst PharmaceuticalsCompletedInfluenzaUnited States, Australia, Canada, Hong Kong, New Zealand, Singapore, South Africa
-
Kirby InstituteActive, not recruitingHepatitis C | HIV | HIV-HCV CoinfectionAustralia
-
Janssen Vaccines & Prevention B.V.CompletedInfluenza, Human Prevention | Respiratory Syncytial Viruses PreventionUnited States
-
GlaxoSmithKlineCureVacActive, not recruitingInfluenza, HumanUnited States, Belgium, South Africa, Canada
-
Kirby InstituteGilead Sciences; The University of New South WalesCompleted
-
Macfarlane Burnet Institute for Medical Research...Recruiting
-
Aegera TherapeuticsTerminatedHuman Mammary CarcinomaUnited States
-
Novartis VaccinesCompletedInfluenzaUnited States
-
Garvan Institute of Medical ResearchCompleted
-
SeqirusNovartis VaccinesCompletedInfluenza | Influenza, Human | Influenza A Virus, H5N1 Subtype | Flu, Human | Flu, AvianAustralia, Germany, Italy
-
GlaxoSmithKlineCompleted
-
Vaxine Pty LtdAustralian Respiratory and Sleep Medicine InstituteNot yet recruiting
-
Bristol-Myers SquibbWithdrawnChronic Hepatitis CAustralia
-
Visterra, Inc.Biomedical Advanced Research and Development AuthorityCompletedInfluenzaUnited States, Estonia, South Africa, Bulgaria, Serbia, Ukraine, Latvia
-
SanofiCompletedInfluenza | Orthomyxoviridae InfectionsUnited States
-
Vaxine Pty LtdFlinders Medical CentreCompletedExposure to Hepatitis B VirusAustralia
-
GlaxoSmithKlineCompletedHepatitis BBelgium, Ukraine, Australia
-
Emergent BioSolutionsCompletedInfluenza | Bird FluUnited States
-
Medical University of South CarolinaNational Institute of Nursing Research (NINR)CompletedFatigue | HIV | Stress Disorder | Human Immunodeficiency VirusUnited States
-
Medical University of South CarolinaCompleted
-
SeqirusCompleted
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, Peru, Romania, Colombia, South Africa, Germany, Russian Federation, Argentina, Mexico
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, China, Germany, South Africa, Russian Federation, Argentina, Brazil, Puerto Rico, Austria, Thailand, Mexico, Uganda
-
Hasanuddin UniversityCompletedTuberculosis | Human Immunodeficiency VirusIndonesia
-
TetraLogic PharmaceuticalsTerminated
-
Intercell USA, Inc.Department of Health and Human ServicesCompleted